Multifunctional microbubbles and nanobubbles for photoacoustic imaging

Contrast Media and Molecular Imaging

Volumn 6, Issue 5, 2011, Pages 401-411

  Xu, Ronald X ^a  

^a Ohio State University   (United States)

Author keywords

Conjugation; Drug delivery; Fluorescence; Microbubble; Multimodal imaging; Nanoballoon; Nanobubble; Nanocapsule; Photoacoustic imaging; Ultrasonography

Indexed keywords

FLUOROCARBON; GOLD NANOPARTICLE; INDIAN INK; INDOCYANINE GREEN; NANOBUBBLE;

ABSORPTION; CHEMICAL MODIFICATION; CIRCULATION; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; ENERGY RESOURCE; HUMAN; IMMUNOGENICITY; MICROBUBBLE; NANOENCAPSULATION; NANOFABRICATION; NONHUMAN; PHOTOACOUSTICS; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY;

CONTRAST MEDIA; DIAGNOSTIC IMAGING; MICROBUBBLES; NANOPARTICLES; PHOTOACOUSTIC TECHNIQUES;

EID: 84860352476     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.442     Document Type: Review

References (113)

1. Sanders RC, Winter TC (eds). Clinical Sonography: a Practical Guide. Lippincott Williams & Wilkins: Philadelphia, PA, 2007.
2. Quaia E. Microbubble ultrasound contrast agents: an update. Eur Radiol 2007; 17(8): 1995-2008.
3. Nanda NC, Carstensen C (eds). Echo-enhancing Agents: Safety. Kluwer Academic Publishers: Boston, 1995.
4. Kiessling F. Science to practice: the dawn of molecular US imaging for clinical cancer imaging. Radiology 2010; 256(2): 331-333.
5. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007; 9: 415-447.
6. Klibanov AL. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006; 41(3): 354-362.
7. Xu JS, Huang J, Qin R, Hinkle GH, Povoski SP, Martin EW, Xu RX. Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging. Biomaterials 2010; 31(7): 1716-1722.
8. Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007; 99(14): 1095-1106.
9. Marsh JN, Partlow KC, Abendschein DR, Scott MJ, Lanza GM, Wickline SA. Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes. Ultrasound Med Biol 2007; 33(6): 950-958.
10. Wang LV. Prospects of photoacoustic tomography. Med Phys 2008; 35(12): 5758-5767.
11. Rosencwaig A, Gersho A. Theory of the photoacoustic effect in solids. J Appl Phys 1976; 47: 64-69.
12. Zhang HF, Maslov K, Wang LV. In vivo imaging of subcutaneous structures using functional photoacoustic microscopy. Nat Protoc 2007; 2(4): 797-804.
13. Maslov K, Zhang HF, Hu S, Wang LV. Optical-resolution photoacoustic microscopy for in vivo imaging of single capillaries. Opt Lett 2008; 33(9): 929-931.
14. Xie Z, Jiao S, Zhang HF, Puliafito CA. Laser-scanning optical-resolution photoacoustic microscopy. Opt Lett 2009; 34(12): 1771-1773.
15. Xu M, Wang LV. Universal back-projection algorithm for photoacoustic computed tomography. Phys Rev E Stat Nonlin Soft Matter Phys 2005; 71(1 Pt 2): 016706.
16. Wang X, Xie X, Ku G, Wang LV, Stoica G. Noninvasive imaging of hemoglobin concentration and oxygenation in the rat brain using high-resolution photoacoustic tomography. J Biomed Opt 2006; 11(2): 024015.
17. Ku G, Wang LV. Deeply penetrating photoacoustic tomography in biological tissues enhanced with an optical contrast agent. Opt Lett 2005; 30(5): 507-509.
18. Song KH, Stein EW, Margenthaler JA, Wang LV. Noninvasive photoacoustic identification of sentinel lymph nodes containing methylene blue in vivo in a rat model. J Biomed Opt 2008; 13(5): 054033.
19. Song KH, Kim C, Cobley CM, Xia Y, Wang LV. Near-infrared gold nanocages as a new class of tracers for photoacoustic sentinel lymph node mapping on a rat model. Nano Lett 2009; 9(1): 183-188.
20. Wang B, Yantsen E, Larson T, Karpiouk AB, Sethuraman S, Su JL, Sokolov K, Emelianov SY. Plasmonic intravascular photoacoustic imaging for detection of macrophages in atherosclerotic plaques. Nano Lett 2009; 9(6): 2212-2217.
21. Li PC, Wang CR, Shieh DB, Wei CW, Liao CK, Poe C, Jhan S, Ding AA, Wu YN. In vivo photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods. Opt Express 2008; 16(23): 18605-18615.
22. Kim C, Qin R, Xu JS, Wang L, Xu RX. Ultrasound and photoacoustic dual-modal imaging of thick biological tissue with microbubble enhancement. J Biomed Opt 2010; 15(1): 010510.
23. Wilson K, Homan K, Emelianov S. Photoacoustic and ultrasound imaging contrast enhancement using a dual contrast agent. Proceedings of SPIE 7564(75642P), 2009.
24. Microbubbles. (accessed 25 January 2011).
25. Correas JM, Bridal L, Lesavre A, Mejean A, Claudon M, Helenon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001; 11(8): 1316-1328.
26. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 2004; 3(6): 527-532.
27. Schneider M, Bussat P, Barrau MB, Arditi M, Yan F, Hybl E. Polymeric microballoons as ultrasound contrast agents. Physical and ultrasonic properties compared with sonicated albumin. Invest Radiol 1992; 27(2): 134-139.
28. El-Sherif DM, Wheatley MA. Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J Biomed Mater Res A 2003; 66(2): 347-355.
29. Straub JA, Chickering DE, Church CC, Shah B, Hanlon T, Bernstein H. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J Control Release 2005; 108(1): 21-32.
30. Wheatley MA, Forsberg F, Oum K, Ro R, El-Sherif D. Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent. Ultrasonics 2006; 44(4): 360-367.
31. Ellegala DB, Leong-Poi H, Carpenter JE, Klibanov AL, Kaul S, Shaffrey ME, Sklenar J, Lindner JE. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation 2003; 108(3): 336-341.
32. Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, Passantino L, Schneider M. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 2010; 45(2): 89-95.
33. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004; 56(11): 1649-1659.
34. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997; 28(1): 5-24.
35. Betancourt T, Brown B, Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. NanomedICINE 2007; 2(2): 219-232.
36. Bejjani RA, BenEzra D, Cohen H, Rieger J, Andrieu C, Jeanny JC, Gollomb G, Behar-Cohen FF. Nanoparticles for gene delivery to retinal pigment epithelial cells. Mol Vis 2005; 11: 124-132.
37. Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 2004; 21(5): 387-422.
38. Saxena V, Sadoqi M, Shao J. Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. Int J Pharm 2006; 308(1-2): 200-204.
39. Betancourt T, Byrne JD, Sunaryo N, Crowder SW, Kadapakkam M, Patel S, Casciato S, Brannon-Peppas L. PEGylation strategies for active targeting of PLA/PLGA nanoparticles. J Biomed Mater Res A 2009; 91(1): 263-276.
40. Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R. PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int J Pharm 2008; 349(1-2): 249-255.
41. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000; 21(23): 2475-2490.
42. Astete CE, Cabliov CM. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed 2006; 17(3): 247-289.
43. Xu R, Huang J, Xu J, Sun D, Hinkle G, Edward J, Martin W, Povoski S. Fabrication of indocyanine green encapsulated biodegradable microbubbles for structural and functional imaging of cancer. J Biomed Opt 2009; 14(3): 034020.
44. Zhang L, Xu JS, Sanders VM, Letson AD, Roberts CJ, Xu RX. Multifunctional microbubbles for image-guided antivascular endothelial growth factor therapy. J Biomed Opt 2010; 15(3): 030515.
45. Zheng W. A water-in-oil-in-oil-in-water (W/O/O/W) method for producing drug-releasing, double-walled microspheres. Int J Pharm 2009; 374(1-2): 90-95.
46. Yuan W, Wu F, Guo M, Jin T. Development of protein delivery microsphere system by a novel S/O/O/W multi-emulsion. Eur J Pharm Sci 2009; 36(2-3): 212-218.
47. Cal K, Sollohub K. Spray drying technique. I: Hardware and process parameters. J Pharm Sci 2010; 99(2): 575-586.
48. Sollohub K, Cal K. Spray drying technique: II. Current applications in pharmaceutical technology. J Pharm Sci 2010; 99(2): 587-597.
49. Snider C, Lee SY, Yeo Y, Gregori GJ, Robinson JP, Park K. Microenvironment-controlled encapsulation (MiCE) process: effects of PLGA concentration, flow rate, and collection method on microcapsule size and morphology. Pharm Res 2008; 25(1): 5-15.
50. Farook U, Stride E, Edirisinghe MJ, Moaleji R. Microbubbling by co-axial electrohydrodynamic atomization. Med Biol Eng Comput 2007; 45(8): 781-789.
51. Jaworek A, Sobczyk AT. Electrospraying route to nanotechnology: an overview. J Electrostat 2008; 66(3-4): 197-219.
52. Loscertales IG, Barrero A, Guerrero I, Cortijo R, Marquez M, Ganan-Calvo AM. Micro/nano encapsulation via electrified coaxial liquid jets. Science 2002; 295(5560): 1695-1698.
53. Enayati M, Ahmad Z, Stride E, Edirisinghe M. One-step electrohydrodynamic production of drug-loaded micro- and nanoparticles. J R Soc Interface 2010; 7(45): 667-675.
54. Chen X, Jia L, Yin X, Cheng J. Spraying modes in coaxial jet electrospray with outer driving liquid. Physics of fluids 2005; 17: 032101.
55. Higuera FJ. Stationary coaxial electrified jet of a dielectric liquid surrounded by a conductive liquid. Phys Fluids 2007; 19: 012102.
56. Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 2005; 102(2): 313-332.
57. Amsden B. The production of uniformly sized polymer microspheres. Pharm Res 1999; 16(7): 1140-1143.
58. Freitas S, Walz A, Merkle HP, Gander B. Solvent extraction employing a static micromixer: a simple, robust and versatile technology for the microencapsulation of proteins. J Microencapsul 2003; 20(1): 67-85.
59. Shiga K, Muramatsu N, Kondo T. Preparation of poly(D, L-lactide) and copoly(lactide-glycolide) microspheres of uniform size. J Pharm Pharmacol 1996; 48(9): 891-895.
60. Benson RC, Kues HA. Fluorescence properties of indocyanine green as related to angiography. Phys Med Biol 1978; 23(1): 159-163.
61. Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci USA 2000; 97(6): 2767-2772.
62. Corlu A, Choe R, Durduran T, Rosen MA, Schweiger M, Arridge SR, Schnall MD, Yodh AG. Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Opt Express 2007; 15(11): 6696-6716.
63. Kupriyanov VV, Nighswander-Rempel S, Xiang B. Mapping regional oxygenation and flow in pig hearts in vivo using near-infrared spectroscopic imaging. J Mol Cell Cardiol 2004; 37(5): 947-957.
64. Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol 2000; 45(1): 15-27.
65. Saxena V, Sadoqi M, Shao J. Enhanced photo-stability, thermal-stability and aqueous-stability of indocyanine green in polymeric nanoparticulate systems. J Photochem Photobiol B 2004; 74(1): 29-38.
66. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005; 1(3): 325-327.
67. Link S, El-Sayed MA. Size and temperature dependence of the plasmon absorption of colloidal gold nanoparticles. J Phys Chem B 1999; 103(42): 4212-4217.
68. Liao H, Hafner JH. Gold nanorod bioconjugates. Chem Mater 2005; 17: 4636-4641.
69. Skirtach AG, Munoz Javier A, Kreft O, Kohler K, Piera Alberola A, Mohwald H, Parak WJ, Sukhorukov GB. Laser-induced release of encapsulated materials inside living cells. Angew Chem Int Ed Engl 2006; 45(28): 4612-4617.
70. Townsend DW. Multimodality imaging of structure and function. Phys Med Biol 2008; 53(4): R1-R39.
71. Hendee WR, Gazelle GS. Biomedical Imaging Research Opportunities Workshop III: a white paper. Ann Biomed Eng 2006; 34(2): 188-198.
72. Hendee WR, Banovac F, Carson PL, DeFronzo RA, Eckelman WC, Fullerton GD, Larson SM, McLennan G, Welch MJ. Biomedical Imaging Research Opportunities Workshop IV: a white paper. Med Phys 2007; 34(2): 673-679.
73. Lang TF, Hasegawa BH, Liew SC, Brown JK, Blankespoor SC, Reilly SM, Gingold EL, Cann CE. Description of a prototype emission-transmission computed tomography imaging system. J Nucl Med 1992; 33(10): 1881-1887.
74. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41(8): 1369-1379.
75. Hammer BE, Christensen NL, Heil BG. Use of a magnetic field to increase the spatial resolution of positron emission tomography. Med Phys 1994; 21(12): 1917-1920.
76. Zhu Q, Conant E, Chance B. Optical imaging as an adjunct to sonograph in differentiating benign from malignant breast lesions. J Biomed Opt 2000; 5(2): 229-236.
77. Li A, Miller EL, Kilmer ME, Brukilacchio TJ, Chaves T, Stott J, Zhang Q, Wu T, Chorlton M, Moore RH, Kopans DB, Boas DA. Tomographic optical breast imaging guided by three-dimensional mammography. Appl Opt 2003; 42(25): 5181-5190.
78. Karpiouk AB, Aglyamov SR, Mallidi S, Shah J, Scott WG, Rubin JM, Emelianov SY. Combined ultrasound and photoacoustic imaging to detect and stage deep vein thrombosis: phantom and ex vivo studies. J Biomed Opt 2008; 13(5): 054061.
79. Jiao S, Xie Z, Zhang HF, Puliafito CA. Simultaneous multimodal imaging with integrated photoacoustic microscopy and optical coherence tomography. Opt Lett 2009; 34(19): 2961-2963.
80. Hoelen CGA, de Mul EFM, Pongers R, Dekker A. Three dimensional photoacoustic imaging of blood vessels in tissue. Opt Lett 1998; 23: 648-650.
81. Kim C, Song KH, Gao F, Wang LV. Sentinel lymph nodes and lymphatic vessels: noninvasive dual-modality in vivo mapping by using indocyanine green in rats-volumetric spectroscopic photoacoustic imaging and planar fluorescence imaging. Radiology 2010; 255(2): 442-450.
82. Klibanov AL, Rasche PT, Hughes MS, Wojdyla JK, Galen KP, Wible JH Jr, Brandenburger GH. Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles. Invest Radiol 2004; 39(3): 187-195.
83. Zhang L, Xu J, Letson A, Roberts C, Xu R. Targeted delivery of multifunctional microbubbles for anti-VEGF therapy of age-related macular degeneration. ARVO 2010 Annual Meeting, Fort Lauderdale, FL, 2010.
84. Xu R, Xu J, Zuo T, Shen R, Huang T, Tweedle M. Drug-loaded biodegradable microspheres for image-guided combinatory epigenetic therapy. J Biomed Opt 2011; 16: 020507.
85. Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Probl Cardiol 2003; 28(12): 625-653.
86. Schmitz G. Ultrasonic imaging of molecular targets. Basic Res Cardiol 2008; 103(2): 174-181.
87. Korpanty G, Carbon JG, Grayburn PA, Fleming JB, Brekken RA. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res 2007; 13(1): 323-330.
88. Lee DJ, Lyshchik A, Huamani J, Hallahan DE, Fleischer AC. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model. J Ultrasound Med 2008; 27(6): 855-866.
89. Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JL, Colcher D. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 1986; 46(2): 850-857.
90. Khattak SF, Chin KS, Bhatia SR, Roberts SC. Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol Bioeng 2007; 96(1): 156-166.
91. Unger EC, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev 2004; 56(9): 1291-1314.
92. Kiessling F, Huppert J, Palmowski M. Functional and molecular ultrasound imaging: concepts and contrast agents. Curr Med Chem 2009; 16(5): 627-642.
93. Kawabata K-I, Sugita N, Yoshikawa H, Azuma T, Umemura S-I. Nanoparticles with multiple perfluorocarbons for controllable ultrasonically induced phase shifting. Jap J Appl Phys 2005; 44(6B): 4548-4552.
94. Kripfgans OD, Fowlkes JB, Miller DL, Eldevik OP, Carson PL. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol 2000; 26(7): 1177-1189.
95. Gao Z, Kennedy AM, Christensen DA, Rapoport NY. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 2008; 48(4): 260-270.
96. Pisani E, Tsapis N, Paris J, Nicolas V, Cattel L, Fattal E. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization. Langmuir 2006; 22(9): 4397-4402.
97. Huang J, Xu JS, Xu RX. Heat-sensitive microbubbles for intraoperative assessment of cancer ablation margins. Biomaterials 2010; 31(6): 1278-1286.
98. Xu RX, Povoski SP, Martin EW Jr. Targeted delivery of microbubbles and nanobubbles for image-guided thermal ablation therapy of tumors. Expert Rev Med Devices 2010; 7(3): 303-306.
99. Apfel R. Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis. US Patent, 5, 840, 276, 1998.
100. Giesecke T, Hynynen K. Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro. Ultrasound Med Biol 2003; 29(9): 1359-1365.
101. VanSonnenberg E, McMullen EM, Solbiati L, Livraghi T, Mueller PR, Silverman SG. Tumor ablation: Principles and Practice. Springer Science + Business Media, New York, 2005.
102. Garrean S, Hering J, Saied A, Hoopes PJ, Helton WS, Ryan TP, Espat NJ. Ultrasound monitoring of a novel microwave ablation (MWA) device in porcine liver: lessons learned and phenomena observed on ablative effects near major intrahepatic vessels. J Gastrointest Surg 2009; 13(2): 334-340.
103. Topp SA, McClurken M, Lipson D, Upadhya GA, Ritter JH, Linehan D, Strasberg SM. Saline-linked surface radiofrequency ablation: factors affecting steam popping and depth of injury in the pig liver. Ann Surg 2004; 239(4): 518-527.
104. Cha CH, Lee FT Jr, Gurney JM, Markhardt BK, Warner TF, Kelcz F, Mahvi DM. CT versus sonography for monitoring radiofrequency ablation in a porcine liver. AJR Am J Roentgenol 2000; 175(3): 705-711.
105. Breen MS, Breen M, Butts K, Chen L, Saidel GM, Wilson DL. MRI-guided thermal ablation therapy: model and parameter estimates to predict cell death from MR thermometry images. Ann Biomed Eng 2007; 35(8): 1391-1403.
106. Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 1994; 10(4): 457-483.
107. Raspet R, Slaton W. Evaporation-condensation effects on resonant photoacoustics of volatile aerosols. J Atmos Ocean Technol 2003; 20(5): 685-695.
108. Arnott WP, Moosmuller H, Sheridan PJ, Ogren JA, Raspet R, Slaton WV, Hand JL, Kreidenweis SM, Collett JL Jr. Photoacoustic and filter-based ambient aerosol light absorption measurements: instrument comparisons and the role of relative humidity. J Geophys Res 108(D1): 4034, doi:4010.1029/2002JD002165 (2003).
109. Pramanik M, Wang LV. Thermoacoustic and photoacoustic sensing of temperature. J Biomed Opt 2009; 14(5): 054024.
110. Shah J, Park S, Aglyamov S, Larson T, Ma L, Sokolov K, Johnston K, Milner T, Emelianov SY. Photoacoustic imaging and temperature measurement for photothermal cancer therapy. J Biomed Opt 2008; 13(3): 034024.
111. Campbell RB. Tumor physiology and delivery of nanopharmaceuticals. Anticancer Agents Med Chem 2006; 6(6): 503-512.
112. Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005; 23(11): 1418-1423.
113. Chappell JC, Price RJ. Targeted therapeutic applications of acoustically active microspheres in the microcirculation. Microcirculation 2006; 13(1): 57-70.